截至2025年8月20日 13:37，上证科创板100指数(000698)上涨0.37%，成分股盛科通信(688702)上涨 17.14%，艾为电子(688798)上涨14.07%，成都华微(688709)上涨12.04%，南芯科技(688484)上涨7.96%， 天奈科技(688116)上涨6.45%。科创100指数ETF(588030)上涨0.17%。最新价报1.21元。拉长时间看，截 至2025年8月19日，科创100指数ETF近1周累计上涨5.21%，涨幅排名可比基金3/12。 流动性方面，科创100指数ETF盘中换手3.27%，成交2.34亿元。拉长时间看，截至8月19日，科创100指 数ETF近1周日均成交4.33亿元，居可比基金第一。 消息面上，2024年受益于AI推动的先进制程投资扩张、HBM产能军备竞赛以及中国半导体自主化浪潮 不断推进，全球半导体设备销售额同比增长10%，达1171亿美元。根据SEMI预测，2025年有望保持良 好增长态势，全年总销售额或将实现1255亿美元。根据2023年中国电子专用设备工业协会数据统计，国 内半导体清洗设备市场规模为113亿元，国产化率为35%，国产化替 ...

Group 1 - The Shanghai Stock Exchange Sci-Tech Innovation Board 100 Index (000698) has shown a strong increase of 2.64% as of August 11, 2025, with notable gains in constituent stocks such as Dongxin Co., Ltd. (688110) up 15.19% and Fengcai Technology (688279) up 11.29% [1] - The Sci-Tech 100 ETF Enhanced Index Fund (588680) has achieved a net value increase of 67.43% over the past year, ranking first among comparable funds and placing in the top 5.55% of index equity funds [1] - The Sci-Tech 100 ETF Enhanced Index Fund has a maximum monthly return of 26.13% since its inception, with the longest consecutive monthly gains being three months and a total increase of 38.67% [1] Group 2 - As of July 31, 2025, the top ten weighted stocks in the Sci-Tech Innovation Board 100 Index account for 23.52% of the index, including companies like Borui Pharmaceutical (688166) and BeiGene (688235) [2] - The market is expected to focus on technology growth and cyclical manufacturing as key themes, with a cautious outlook on high-valuation stocks facing performance verification pressure during the earnings report peak in August [2] - The technology sector's valuation is currently around 50% of historical levels, with certain segments like semiconductor materials and 6G showing higher valuation levels compared to their historical averages [2] Group 3 - The Sci-Tech 100 ETF Enhanced Index Fund provides investors with a convenient tool to invest in small and medium-sized companies on the Sci-Tech Board, allowing for easy access to excess returns from these enterprises [3]

Core Viewpoint - The article highlights the strong performance of the Sci-Tech Innovation 100 Index and its ETF, driven by advancements in robotics and related technologies, particularly in the context of the 2025 World Robot Conference held in Beijing [3][4]. Group 1: Market Performance - As of August 11, 2025, the Sci-Tech Innovation 100 Index rose by 1.07%, with notable gains from constituent stocks such as Shengyi Electronics (up 8.73%) and Huazhu High-Tech (up 8.27%) [3]. - The Sci-Tech 100 Index ETF increased by 1.08%, with a latest price of 1.13 yuan, and has seen a 2.01% rise over the past week, ranking 2nd among comparable funds [3]. - The ETF's trading volume was 16.11 million yuan, with a turnover rate of 0.25% [3]. Group 2: Industry Insights - The integration of cutting-edge technologies like AI, biomimicry, and new materials is driving the robotics industry towards intelligent upgrades and large-scale applications [4]. - The revenue for the robotics industry is projected to reach nearly 240 billion yuan in 2024, with industrial robot production expected to grow by 35.6% year-on-year in the first half of 2025 [4]. Group 3: ETF Performance Metrics - The Sci-Tech 100 Index ETF has seen a net value increase of 15.76% over the past six months, ranking in the top 17.25% among equity funds [5]. - The ETF's highest monthly return since inception was 27.67%, with an average monthly return of 8.48% during rising months [5]. - The ETF's management fee is 0.15%, and its tracking error over the past month is 0.013%, indicating high tracking precision compared to similar funds [5][6]. Group 4: Fund Growth - The Sci-Tech 100 Index ETF experienced a significant growth in scale, increasing by 52.16 million yuan over the past week, ranking 2nd among comparable funds [4]. - The ETF's share count rose by 27 million shares in the same period, ranking 3rd among comparable funds [4]. Group 5: Top Holdings - As of July 31, 2025, the top ten weighted stocks in the Sci-Tech Innovation 100 Index accounted for 23.52% of the index, including companies like Borui Pharmaceutical and BeiGene [6].

Group 1 - The Shanghai Stock Exchange Sci-Tech Innovation Board 100 Index (000698) has shown a slight increase of 0.28% as of August 5, 2025, with notable gains from individual stocks such as Borui Pharmaceutical (688166) up by 6.56% and Huaheng Biological (688639) up by 5.88% [3][4] - The Sci-Tech 100 Index ETF (588030) has reported a 1.74% increase over the past week, with a current price of 1.11 yuan and a trading volume of 1.14 billion yuan [3][4] - The ETF has experienced a significant growth in scale, increasing by 13.55 million yuan over the past year, ranking first among comparable funds [4] Group 2 - The Shanghai Municipal Government has issued measures to support enterprises in enhancing basic research, particularly in critical fields such as integrated circuits, biomedicine, and artificial intelligence [4] - According to CITIC Securities, mainstream and niche storage prices are expected to rise in Q3 2025, with a focus on recommending leading storage chip design companies [4] - The latest financing buy-in amount for the Sci-Tech 100 Index ETF reached 11.4961 million yuan, with a financing balance of 177 million yuan [4] Group 3 - The Sci-Tech 100 Index ETF has achieved a net value increase of 22.98% over the past six months, ranking in the top 9.90% among equity funds [5] - The ETF has a management fee rate of 0.15% and a custody fee rate of 0.05%, which are among the lowest in comparable funds [5] - The ETF closely tracks the Sci-Tech Innovation Board 100 Index, which consists of 100 securities selected for their market capitalization and liquidity [6]

Core Viewpoint - The trading volume of the Shanghai Stock Exchange Science and Technology Innovation Board 100 Index ETF reached 1.028 billion yuan today, marking a 30.74% increase compared to the previous trading day [1] Trading Volume Summary - The Science and Technology 100 ETF Fund (588220) had a trading volume of 263 million yuan, an increase of 101 million yuan, representing a 61.82% rise [1] - The Science and Technology 100 (588190) recorded a trading volume of 230 million yuan, up by 76.02 million yuan, with a 49.40% increase [1] - The Bosera Science and Technology 100 ETF (588030) saw a trading volume of 241 million yuan, increasing by 37.39 million yuan, which is an 18.32% rise [1] - The trading volumes of the GF Shanghai Stock Exchange Science and Technology Innovation Board 100 Enhanced Strategy ETF (588680) and the E Fund Shanghai Stock Exchange Science and Technology Innovation Board 100 Enhanced Strategy ETF (588500) increased by 161.51% and 98.03% respectively [1] Market Performance Summary - As of market close, the Shanghai Stock Exchange Science and Technology Innovation Board 100 Index (000698) rose by 1.81%, while the average increase of related ETFs was 1.86% [1] - The top performers included the Southern Shanghai Stock Exchange Science and Technology Innovation Board 100 ETF (588900) and the E Fund Shanghai Stock Exchange Science and Technology Innovation Board 100 Enhanced Strategy ETF (588500), which increased by 2.03% and 2.01% respectively [1]

Core Viewpoint - The Chinese innovative pharmaceutical industry is transitioning from imitation to original innovation, with significant growth in outbound transactions and a promising future for internationalization [4] Group 1: Market Performance - As of May 29, 2025, the Sci-Tech Innovation Board 100 Index (000698) rose by 1.63%, with notable increases in constituent stocks such as Borui Pharmaceutical (688166) up 9.66% and Zhixiang Jintai (688443) up 6.57% [3] - The Sci-Tech 100 Index ETF (588030) increased by 1.60%, with a latest price of 0.95 yuan and a turnover rate of 1.16%, totaling 71.56 million yuan in transactions [3] - Over the past year, the average daily transaction volume of the Sci-Tech 100 Index ETF reached 424 million yuan, ranking first among comparable funds [3] Group 2: Fund Growth and Performance - The Sci-Tech 100 Index ETF saw a significant increase in scale, growing by 94.45 million yuan over the past two weeks, ranking second among comparable funds [4] - In the past week, the ETF's shares increased by 99 million, also ranking first among comparable funds [5] - The ETF has experienced a net inflow of 71.08 million yuan over the last five trading days, indicating strong investor interest [5] Group 3: Financial Metrics - As of May 28, 2025, the Sci-Tech 100 Index ETF's net value increased by 19.94% over the past year, with a maximum monthly return of 27.67% since inception [5] - The ETF's management fee is 0.15% and the custody fee is 0.05%, making it the lowest among comparable funds [5] - The tracking error for the ETF over the past six months is 0.016%, indicating high tracking precision compared to similar funds [5] Group 4: Industry Insights - From the beginning of 2025 to the present, the total outbound transaction amount for innovative drugs has reached 45.5 billion USD, with upfront payments totaling 2.2 billion USD, suggesting a record year ahead [4] - Most domestic innovative drugs currently in the U.S. are in clinical stages, with significant potential for future growth as they progress towards commercialization [4]

Group 1 - The National Bureau of Statistics has issued the "Digital China Construction 2025 Action Plan," emphasizing the development of artificial intelligence applications and high-quality data sets [1] - The Shanghai Stock Exchange Science and Technology Innovation Board 100 Index aligns with current technology development trends, focusing on emerging industries such as pharmaceuticals, electronics, and intelligent manufacturing [1] - The index consists of 100 medium-cap and liquid securities, with nearly 90% of the weight in five key sectors, and over 50% of the weight in "specialized, refined, and innovative" enterprises [1] Group 2 - Public funds have increased their allocation to the Science and Technology Innovation Board, with a rise of 2.4 percentage points to 15.6%, indicating a significant overweight position [2] - The GF Science and Technology 100 ETF Enhanced employs quantitative strategies to focus on the self-controlled industrial chain and aims to uncover excess returns [2] - Since its inception, the GF Science and Technology 100 ETF Enhanced has achieved a cumulative return of 43.73%, outperforming its benchmark by 31.98% [2]

规模方面，科创100指数ETF近1年规模增长3.71亿元，实现显著增长，新增规模位居可比基金2/10。 份额方面，科创100指数ETF近2周份额增长1.14亿份，实现显著增长，新增份额位居可比基金2/10。 资金流入方面，科创100指数ETF近4个交易日内有3日资金净流入，合计"吸金"6572.26万元，日均净流入达1643.06万元。 数据显示，杠杆资金持续布局中。科创100指数ETF前一交易日融资净买额达403.64万元，最新融资余额达3.32亿元。 截至2025年4月10日 10:10，上证科创板100指数(000698)强势上涨4.56%，成分股生益电子(688183)上涨13.18%，华曙高科(688433)上涨12.94%，道通科技 (688208)上涨12.70%，铂力特(688333)，奥普特(688686)等个股跟涨。科创100指数ETF(588030)上涨4.37%， 冲击3连涨。最新价报0.93元。拉长时间看，截 至2025年4月9日，科创100指数ETF近3月累计上涨4.44%。 流动性方面，科创100指数ETF盘中换手3.81%，成交2.29亿元。拉长时间看，截至4月9日，科创100 ...